 Peter Hountras
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 2 | 2020 | 177 | 1.520 |
Why?
| | Thrombectomy | 2 | 2020 | 34 | 1.100 |
Why?
| | Chest Pain | 2 | 2020 | 83 | 0.990 |
Why?
| | Antiphospholipid Syndrome | 1 | 2020 | 26 | 0.890 |
Why?
| | Heart Atria | 1 | 2020 | 132 | 0.830 |
Why?
| | Thrombolytic Therapy | 1 | 2020 | 113 | 0.820 |
Why?
| | Hemoptysis | 1 | 2019 | 31 | 0.800 |
Why?
| | Pulmonary Edema | 1 | 2019 | 158 | 0.760 |
Why?
| | Cough | 1 | 2019 | 98 | 0.760 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2020 | 211 | 0.750 |
Why?
| | Coccidioidomycosis | 1 | 2017 | 3 | 0.730 |
Why?
| | Thrombosis | 1 | 2020 | 244 | 0.730 |
Why?
| | Lung Diseases, Fungal | 1 | 2017 | 15 | 0.730 |
Why?
| | Fibrinolytic Agents | 1 | 2020 | 225 | 0.720 |
Why?
| | Respiratory Sounds | 1 | 2017 | 90 | 0.680 |
Why?
| | Pulmonary Alveoli | 1 | 2019 | 380 | 0.640 |
Why?
| | Anticoagulants | 1 | 2020 | 509 | 0.640 |
Why?
| | Seizures | 1 | 2019 | 318 | 0.630 |
Why?
| | Respiratory Insufficiency | 1 | 2017 | 273 | 0.560 |
Why?
| | Pneumonia, Bacterial | 3 | 2019 | 106 | 0.530 |
Why?
| | Hypoxia | 1 | 2019 | 934 | 0.490 |
Why?
| | Vena Cava Filters | 2 | 2020 | 34 | 0.430 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2019 | 35 | 0.370 |
Why?
| | Acute Disease | 2 | 2020 | 993 | 0.320 |
Why?
| | Respiration, Artificial | 3 | 2019 | 551 | 0.320 |
Why?
| | Critical Care | 2 | 2017 | 466 | 0.260 |
Why?
| | Endarterectomy | 1 | 2020 | 5 | 0.230 |
Why?
| | Conversion to Open Surgery | 1 | 2020 | 13 | 0.230 |
Why?
| | Embolectomy | 1 | 2020 | 10 | 0.220 |
Why?
| | Dyspnea | 1 | 2020 | 187 | 0.200 |
Why?
| | Metagenomics | 1 | 2019 | 124 | 0.190 |
Why?
| | Tomography, X-Ray Computed | 2 | 2019 | 2385 | 0.180 |
Why?
| | Endovascular Procedures | 1 | 2020 | 160 | 0.180 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 171 | 0.180 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 280 | 0.170 |
Why?
| | Pulmonary Medicine | 1 | 2017 | 84 | 0.160 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 314 | 0.160 |
Why?
| | Patient Care Team | 1 | 2020 | 517 | 0.150 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 373 | 0.150 |
Why?
| | Biopsy | 1 | 2019 | 1082 | 0.150 |
Why?
| | Cross Infection | 1 | 2017 | 195 | 0.150 |
Why?
| | Diagnosis, Differential | 1 | 2019 | 1459 | 0.140 |
Why?
| | Bacteria | 1 | 2019 | 642 | 0.130 |
Why?
| | Societies, Medical | 1 | 2017 | 756 | 0.130 |
Why?
| | Humans | 10 | 2020 | 109171 | 0.120 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1541 | 0.120 |
Why?
| | Microbiota | 1 | 2017 | 460 | 0.120 |
Why?
| | Curriculum | 1 | 2017 | 753 | 0.110 |
Why?
| | Middle Aged | 4 | 2019 | 28539 | 0.110 |
Why?
| | Female | 6 | 2020 | 61606 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2019 | 1280 | 0.100 |
Why?
| | Treatment Outcome | 1 | 2020 | 8928 | 0.080 |
Why?
| | Adult | 4 | 2020 | 31455 | 0.070 |
Why?
| | Lung | 1 | 2017 | 3515 | 0.070 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 177 | 0.040 |
Why?
| | Dental Plaque | 1 | 2017 | 28 | 0.040 |
Why?
| | Probiotics | 1 | 2017 | 47 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2019 | 647 | 0.040 |
Why?
| | Education, Medical, Continuing | 1 | 2017 | 138 | 0.040 |
Why?
| | Pilot Projects | 1 | 2019 | 1391 | 0.040 |
Why?
| | Respiratory Distress Syndrome, Adult | 1 | 2017 | 338 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2017 | 417 | 0.030 |
Why?
| | Achievement | 1 | 1970 | 60 | 0.030 |
Why?
| | Aged | 2 | 2019 | 19759 | 0.030 |
Why?
| | Cohort Studies | 1 | 2019 | 4804 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3843 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 6709 | 0.020 |
Why?
| | Students | 1 | 1970 | 473 | 0.020 |
Why?
| | Anxiety | 1 | 1970 | 707 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2019 | 10640 | 0.020 |
Why?
| | Male | 3 | 2019 | 60174 | 0.020 |
Why?
| | United States | 2 | 2017 | 11627 | 0.020 |
Why?
| | Young Adult | 1 | 2019 | 10686 | 0.020 |
Why?
| | Mice | 1 | 2019 | 14934 | 0.020 |
Why?
| | Animals | 1 | 2019 | 34608 | 0.010 |
Why?
| | Social Desirability | 1 | 1970 | 16 | 0.010 |
Why?
| | Psychological Tests | 1 | 1970 | 143 | 0.010 |
Why?
| | Canada | 1 | 1970 | 329 | 0.010 |
Why?
| | Universities | 1 | 1970 | 353 | 0.010 |
Why?
|
|
Hountras's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|